CYCLERION THERAPEUTICS, INC. Defined Contribution Plan, Cost
CYCLERION THERAPEUTICS, INC. (CYCN) reported Defined Contribution Plan, Cost of $100.00 thousand for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2025-11-12
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2023-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2023-09-30 was $100.00K, a 50.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2023-06-30 was $100.00K, a 50.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2023-03-31 was $100.00K, a 50.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2024 was $100.00K, a 0.00% change from fiscal 2023.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2023 was $100.00K, a 50.00% decline from fiscal 2022.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2022 was $200.00K, a 33.33% decline from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2021 was $300.00K, a 40.00% decline from fiscal 2020.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 3 month as first filed | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $100.00K 10-K/A · filed 2025-11-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $100.00K derived: sum of 2 quarters · filed 2025-11-12 | $200.00K derived: sum of 3 quarters · filed 2025-11-12 | $100.00K 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-13 | $200.00K derived: sum of 2 quarters · filed 2023-11-13 | $100.00K 10-Q · filed 2023-11-13 | $300.00K derived: sum of 4 quarters · filed 2024-03-05 | |
| 2023-06-30 | $100.00K 10-Q · filed 2023-07-28 | $100.00K 10-Q · filed 2023-07-28 | $200.00K derived: sum of 3 quarters · filed 2024-03-05 | $400.00K derived: sum of 4 quarters · filed 2024-03-05 | |
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-12 | $100.00K derived: sum of 2 quarters · filed 2024-03-05 | $300.00K derived: sum of 3 quarters · filed 2024-03-05 | $500.00K derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $200.00K derived: sum of 2 quarters · filed 2024-03-05 | $400.00K derived: sum of 3 quarters · filed 2024-03-05 | $200.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-13 | $400.00K derived: sum of 2 quarters · filed 2023-11-13 | $200.00K 10-Q · filed 2023-11-13 | $400.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $200.00K 10-Q · filed 2023-07-28 | $200.00K 10-Q · filed 2023-07-28 | $200.00K derived: sum of 3 quarters · filed 2023-07-28 | $700.00K derived: sum of 4 quarters · filed 2023-07-28 | |
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-12 | $100.00K 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $500.00K derived: sum of 3 quarters · filed 2023-05-12 | $700.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $300.00K derived: sum of 2 quarters · filed 2023-03-22 | $500.00K derived: sum of 3 quarters · filed 2023-03-22 | $300.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $500.00K 10-Q · filed 2022-11-03 | $700.00K derived: sum of 2 quarters · filed 2022-11-03 | $500.00K 10-Q · filed 2022-11-03 | $1.00M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-09 | $200.00K 10-Q · filed 2022-08-09 | $500.00K derived: sum of 3 quarters · filed 2022-08-09 | $900.00K derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-04 | $300.00K derived: sum of 2 quarters · filed 2022-05-04 | $700.00K derived: sum of 3 quarters · filed 2022-05-04 | $800.00K derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $500.00K derived: sum of 2 quarters · filed 2022-02-24 | $600.00K derived: sum of 3 quarters · filed 2022-02-24 | $500.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $400.00K 10-Q · filed 2021-11-09 | $500.00K derived: sum of 2 quarters · filed 2021-11-09 | $400.00K 10-Q · filed 2021-11-09 | $900.00K derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $100.00K 10-Q · filed 2021-07-29 | $400.00K 10-Q · filed 2021-07-29 | $500.00K derived: sum of 3 quarters · filed 2021-07-29 | $600.00K derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | $300.00K 10-Q · filed 2021-04-30 | $400.00K derived: sum of 2 quarters · filed 2021-04-30 | $500.00K derived: sum of 3 quarters · filed 2021-04-30 | $600.00K derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $200.00K derived: sum of 2 quarters · filed 2021-02-25 | $300.00K derived: sum of 3 quarters · filed 2021-02-25 | $600.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-05 | $200.00K derived: sum of 2 quarters · filed 2020-11-05 | $500.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-03 | $500.00K 10-Q · filed 2020-08-03 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $400.00K derived: sum of 2 quarters · filed 2020-03-12 | $700.00K derived: sum of 3 quarters · filed 2020-03-12 | $400.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $400.00K 10-Q · filed 2019-11-12 | $700.00K derived: sum of 2 quarters · filed 2019-11-12 | $400.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $300.00K 10-Q · filed 2019-08-12 | $600.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |